Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine.
Clinical trial NCT01848652 · TERMINATED
Trial details
- NCT number
- NCT01848652
- Sponsor
- University Hospital, Brest
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.